3 Recruiting Aggressive Variant Prostate Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Related Conditions
Top Recruiting Aggressive Variant Prostate Carcinoma Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Zanzalintinib in Men With Aggressive Variant Prostate Cancer
📍 Froedtert and The Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔